Drug profile

The FDA adverse-event record for Unspecified Medicated Shampoo

26 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Medicated Shampoo. See the species affected, top reactions, and outcomes below.

26
adverse-event reports
15.4%
death-coded share
Dog
most-reported species
6
Lack of efficacy (ectoparasite) - flea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
26
Total Reports
4
Deaths Reported
15.4%
Death Rate

Active Ingredients

Unspecified Medicated Shampoo

Administration Routes

TopicalUnknown

Species Affected

Dog 26

Most Affected Breeds

Retriever - Labrador 3
Terrier - Yorkshire 2
Retriever - Golden 2
Dog (unknown) 2
Shepherd Dog - Belgian Malinois 2
Rottweiler 1
Beagle 1
Collie (unspecified) 1
Pit Bull 1
Havanese 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 6
Hair loss NOS 4
Skin lesion NOS 3
Pruritus 3
Anorexia 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Weight loss 3
Behavioural disorder NOS 3
Death 3
Skin and tissue infection NOS 3
Erythema (for urticaria see Immune SOC) 2
Vocalisation 2

Outcome Breakdown

Outcome Unknown
9 (34.6%)
Recovered/Normal
7 (26.9%)
Ongoing
6 (23.1%)
Died
3 (11.5%)
Euthanized
1 (3.8%)

Unspecified Medicated Shampoo Adverse Event Insights

26 reports name Unspecified Medicated Shampoo; 4 recorded a death outcome (15.4% of reported events, not a population-level mortality rate). Active ingredient: Unspecified Medicated Shampoo. Administration routes: Topical, Unknown.

By species: Dog (26 reports). By breed: Retriever - Labrador (3), Terrier - Yorkshire (2), Retriever - Golden (2).

Leading clinical signs: Lack of efficacy (ectoparasite) - flea (6), Hair loss NOS (4), Skin lesion NOS (3), Pruritus (3). Outcome, 26 coded reports: Outcome Unknown leads at 34.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.